DTNBP1 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-DTNBP1 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | DTNBP1 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.05 mL, 0.1 mL, 0.2 mL |
| Concentration | 1mg/ml |
| Applications | Western Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Dysbindin, or dystrobrevin-binding protein 1, is a coiled-coil-containing protein expressed in muscle and brain that was identified as a binding partner of dystrobrevin (1). Dysbindin upregulates expression of the pre-synaptic proteins SNAP25 and synapsin I, thereby increasing glutamate release and promoting neuronal viability through Akt signaling. In particular, Akt phosphorylation is suppressed with downregulation of dysbindin and increased with upregulation of dysbindin (2). A nonsense mutation of dysbindin causes Hermansky-Pudlak disease, an autosomal recessive disorder characterized by lysosomal storage defects and prolonged bleeding. (2). Genetic variation in the gene encoding dysbindin is strongly associated with schizophrenia and p |
| Immunogen | Immunogen: Recombinant Protein |
| Other Names | [DBND; DKFZp564K192; FLJ30031; HPS7; MGC20210; My031; SD], [DTNBP1; DTNBP1; SDY; DBND; HPS7; My031; BLOC1S8; BLOC1S8; BLOC-1 subunit 8; HPS7 protein] |
| Gene, Accession # | [DTNBP1], Gene ID: 84062, NCBI: Q96EV8.1, UniProt: Q96EV8 |
| Catalog # | MBS127516 |
| Price | $200, $275, $430 |
| Order / More Info | DTNBP1 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies